Skip to main content

Table 5 Comparison of preceding major case studies

From: Triple platelet inhibition in intracranial thrombectomy with additional acute cervical stent angioplasty due to tandem lesion: a retrospective single-center analysis

Author (year)

N

ICA re-occlusion at 24 h

sICH

mRS 0–2 at 90d

APT

Allard et al. (2023) [14]

225

20.9%

n.a.*

54.7%

COXI and P2Y12 or GP-IIb/IIIa-I

Renú et al. (2020) [15]

99

22%

4%

66.7%

COXI and P2Y12

Bricout et al. (2018) [6]

83

55.4%

12.1%

41%

COXI

Marnat et al. (2020) [3]

65

56.9%

10.8%

54%

n.a.

Data in this study

176

0%

2.3%

45%

COXI and P2Y12 and GP-IIb/IIIa-I

  1. Abbreviations: Cyclooxygenase Inhibitor - COXI; Glycoprotein IIb/IIIa inhibitor - GP-IIb/IIIa-I; P2Y12-antagnosit P2Y12. * Authors do not differentiate symptomatic and any intracerebral hematoma